Lab2Launch entrepreneurship@UBC’s Lab2Launch venture building program is for UBC researchers and scientists who are focusing on the development of a scientific or technological innovation which is unique, proprietary and difficult to reproduce,… Read More
On behalf of the Board of Directors and staff, I am pleased to share with you a copy of the Genome British Columbia Annual Report for the fiscal year 2019/2020, celebrating… Read More
Vancouver, BC – July 7, 2020 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and… Read More
July 1, 2020 – Vancouver, B.C. – Acuitas Therapeutics, a Vancouver-based biotechnology company that specializes in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticles (LNP),… Read More
SEATTLE, July 02, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc. (“Neoleukin”) (Nasdaq: NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the pricing of an underwritten public offering of… Read More
